TP53 and colorectal cancer: Nonetheless, more and more meta-analysis evidence obtained by pooling all the currently available case-control studies to estimate the effect and distribution of p53 codon 72 Arg/Pro polymorphism on cancer susceptibility has indicated that the polymorphism is not associated with overall cancer odds in several populations, including Iranian [41] and Chinese [42] colorectal cancer patients [43].